NF-κB is a critical transcription factor that is regulated by several post-transcriptional modifications. The characterization of their roles would help in the design of new therapeutic targets in cancer and inflammation.
References
Ghosh, S. & Hayden, M.S. Nat. Rev. Immunol. 8, 837–848 (2008).
Levy, D. et al. Nat. Immunol. 12, 29–36 (2010).
Zhong, H., May, M.J., Jimi, E. & Ghosh, S. Mol. Cell 9, 625–636 (2002).
Chen, L.F. et al. Mol. Cell. Biol. 25, 7966–7975 (2005).
Duran, A., Diaz-Meco, M.T. & Moscat, J. EMBO J. 22, 3910–3918 (2003).
Leitges, M. et al. Mol. Cell 8, 771–780 (2001).
Karin, M. Nature 441, 431–436 (2006).
Tachibana, M., Matsumura, Y., Fukuda, M., Kimura, H. & Shinkai, Y. EMBO J. 27, 2681–2690 (2008).
Moscat, J., Diaz-Meco, M.T. & Wooten, M.W. Cell Death Differ. 16, 1426–1437 (2009).
De Santa, F. et al. Cell 130, 1083–1094 (2007).
Lallena, M.J., Diaz-Meco, M.T., Bren, G., Pay, C.V. & Moscat, J. Mol. Cell. Biol. 19, 2180–2188 (1999).
Author information
Authors and Affiliations
Corresponding author
Ethics declarations
Competing interests
The authors declare no competing financial interests.
Rights and permissions
About this article
Cite this article
Moscat, J., Diaz-Meco, M. Fine tuning NF-κB: new openings for PKC-ζ. Nat Immunol 12, 12–14 (2011). https://doi.org/10.1038/ni0111-12
Published:
Issue Date:
DOI: https://doi.org/10.1038/ni0111-12
- Springer Nature America, Inc.